Emma Groarke: Somatic Mutations and Chromosomal Abnormalities in Bone Marrow Failure
Emma Groarke, Associate Research Physician at the National Institutes of Health, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Journals, adding:
“Really excited to see our National Heart, Lung, and Blood Institute How-I-Treat now published in this week’s issue of Blood Journals Portfolio !
Our aim was to provide a practical clinical guide to the interpretation of chromosomal abnormalities and somatic mutations in the context of both immune and germline bone marrow failure. Such somatic alterations can be incorporated into the diagnosis and surveillance for patients with BMF!
We also specifically provide a (hopefully) useful guideline for interpreting somatic mutations / abnormal karyotype before and after IST for SAA
Thanks to my colleagues Bhavisha Patel and Fernanda Gutierrez-Rodrigues, PhD my forever co-authors !”
Title: How I utilize somatic alterations in the diagnosis, risk stratification, and therapy of hypocellular bone marrow failure
Authors: Emma M. Groarke, Fernanda Gutierrez-Rodrigues, Bhavisha A. Patel
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 24, 2026, 15:15Jim Hoffman: Could Targeting NETosis Reduce Long-Term Risk After STEMI?
-
Aug 24, 2026, 14:58Danny Hsu: Rethinking Bleeding Risk in Patients on Anticoagulation
-
Aug 24, 2026, 14:18The Way to a Safer Workplace for People With Bleeding Disorders – EHC
-
Aug 24, 2026, 14:09Stuart Andrew: NHS Blood and Transplant Strengthening the Blood Supply
-
Aug 24, 2026, 14:05Edward Lee Carter: Anticoagulation Stewardship is Moving From Recommendation to Measurement
-
Aug 24, 2026, 13:58Meera Chitlur: Transforming Care for Heavy Menstrual Bleeding at Children’s Hospital of Michigan
-
Aug 24, 2026, 13:49Heghine Khachatryan: Prepartum Acquired Hemophilia A and the Challenge of Maternal and Neonatal Bleeding
-
Aug 24, 2026, 13:44Neeraj Songara: Therapeutic Plasma Exchange in Severe Guillain–Barré Syndrome
-
Aug 24, 2026, 13:42Pall T. Onundarson: The Role of Measuring Treatment Effect in Optimizing DOAC and Warfarin Therapy